Diffuse follicle center lymphoma, extrnodal and solid organ sites, is a type of non-Hodgkin lymphoma characterized by the proliferation of neoplastic B-cells in lymphoid tissues outside of the lymph nodes, including solid organs. This condition is clinically significant due to its potential for aggressive behavior and varied presentation, necessitating accurate diagnosis and treatment. The ICD-10 Code C82.59 facilitates precise documentation, billing, and public health reporting, ensuring appropriate resource allocation and patient management.
ICD-10 Code C82.59 represents Diffuse follicle center lymphoma occurring in extrnodal and solid organ sites. This condition involves malignant transformation of B-lymphocytes, leading to lymphoid tissue infiltration outside the lymph nodes. This code should be used in clinical documentation and billing when diagnosing patients with this specific type of lymphoma, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
Diffuse follicle center lymphoma, extrnodal and solid organ sites, is primarily caused by genetic mutations leading to uncontrolled proliferation of B-cells. The condition can progress rapidly, resulting in significant morbidity and necessitating prompt medical intervention. Early diagnosis is crucial for effective management and treatment.
ICD-10 Code C82.59 is utilized in SOAP notes to document the patient's symptoms, assessment, and treatment plan for diffuse follicle center lymphoma. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's clinical status and guiding treatment decisions.
In SOAP notes, ICD-10 Code C82.59 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of diffuse follicle center lymphoma. This code supports continuity of care, facilitates accurate billing, and meets EHR documentation standards.
Prompt treatment for diffuse follicle center lymphoma is critical due to its aggressive nature. Management typically involves chemotherapy and may require hospitalization.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.59 is essential for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 85025 | Complete blood count (CBC) with automated differential white blood cell count. |
| 77014 | Radiologic examination, lymphatic system, including imaging. |
Common Questions About Using ICD-10 Code C82.59 for Diffuse folicl center lymph, extrnod and solid organ sites
What are the common symptoms of diffuse follicle center lymphoma?
Common symptoms include unexplained weight loss, fever, night sweats, and lymphadenopathy. Patients may also experience fatigue and organomegaly.
How is diffuse follicle center lymphoma diagnosed?
Diagnosis typically involves a combination of clinical evaluation, imaging studies, and histological confirmation through biopsy of affected tissues.
What treatment options are available for this condition?
Treatment often includes chemotherapy regimens tailored to the patient's specific condition, along with supportive care to manage symptoms and complications.
Is hospitalization required for patients with this diagnosis?
Hospitalization may be necessary for patients requiring intensive treatment, monitoring for complications, or supportive care due to the aggressive nature of the disease.
Clinical Notes
SOAP notes
DAP notes
AI medical notes